On Drugs Inc
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2011 | 400,117 | 403,058 | −2,941 | 8.3 | 44% |
| 2012 | 391,380 | 340,648 | 50,732 | 11.7 | 47% |
| 2013 | 338,116 | 260,358 | 77,758 | 18.8 | 39% |
| 2014 | 303,342 | 355,879 | −52,537 | 12.0 | 45% |
| 2015 | 338,184 | 355,949 | −17,765 | 11.4 | 48% |
| 2016 | 304,693 | 346,247 | −41,554 | 10.3 | 49% |
| 2017 | 326,446 | 355,260 | −28,814 | 9.1 | 48% |
| 2018 | 342,914 | 400,124 | −57,210 | 6.3 | 52% |
| 2019 | 422,458 | 402,752 | 19,706 | 6.9 | 53% |
| 2020 | 422,050 | 353,786 | 68,264 | 10.1 | 49% |
| 2021 | 539,808 | 433,124 | 106,684 | 11.3 | 49% |
| 2022 | 455,030 | 405,798 | 49,232 | 13.6 | 58% |
| 2023 | 498,633 | 540,977 | −42,344 | 9.2 | 53% |
In its most recent public year (2023), this organization spent $42,344 more than it brought in. Its reserves stood at about 9.2 months of spending. Staff pay was 53% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
On Drugs Inc's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works